£44.44

CRC Press Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

Price data last checked 108 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 5 months ago.

£44 today · all-time low £44 (Dec 2025) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 174 days • 174 data points (No recent data available)

Historical
Generating forecast...
£45.05 £44.34 £44.49 £44.65 £44.80 £44.96 £45.11 01 September 2025 14 October 2025 26 November 2025 08 January 2026 21 February 2026

Price Distribution

Price distribution over 174 days • 2 price levels

Days at Price
Current Price
163 days · current 11 days 0 41 82 122 163 £44 £45 Days at Price

Price Analysis

Most common price: £44 (163 days, 93.7%)

Price range: £44 - £45

Price levels: 2 different prices over 174 days

Description

Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book systematically covering the latest development in the field. Written specifically for pharmaceutical practitioners, Real-World Evidence in Drug Development and Evaluation, presents a wide range of RWE applications throughout the lifecycle of drug product development. With contributions from experienced researchers in the pharmaceutical industry, the book discusses at length RWE opportunities, challenges, and solutions. Features Provides the first book and a single source of information on RWE in drug development Covers a broad array of topics on outcomes- and value-based RWE assessments Demonstrates proper Bayesian application and causal inference for real-world data (RWD) Presents real-world use cases to illustrate the use of advanced analytics and statistical methods to generate insights Offers a balanced discussion of practical RWE issues at hand and technical solutions suitable for practitioners with limited data science expertise

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
29 August 2022
Listed Since
03 June 2022

Barcode

No barcode data available

Similar Products You Might Like

Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
99% match

Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£119.60 23 Feb 2026
Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)
97% match

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£48.33 20 Feb 2026
Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)
97% match

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£85.00 08 Mar 2026
Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)
97% match

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£42.72 01 Mar 2026
Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)
97% match

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£97.00 09 Mar 2026
Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)
96% match

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£60.89 06 Mar 2026
Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)
96% match

Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£80.00 13 Apr 2026
Springer - Real-World Evidence in Medical Product Development
96% match

Springer - Real-World Evidence in Medical Product Development

Springer

£102.00 23 Feb 2026
Statistical Issues in Drug Development (Statistics in Practice)
96% match

Statistical Issues in Drug Development (Statistics in Practice)

Wiley

£71.59 22 Jan 2026
Exposure-Response Modeling: Methods and Practical Implementation (Chapman & Hall/CRC Biostatistics Series)
96% match

Exposure-Response Modeling: Methods and Practical Implementation (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£48.33 22 Feb 2026
Causal Inference in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)
96% match

Causal Inference in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£93.91 08 Mar 2026
Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)
96% match

Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£141.70 08 Feb 2026
Statistical Methods in Biomarker and Early Clinical Development
96% match

Statistical Methods in Biomarker and Early Clinical Development

£104.17 12 Jan 2026
Statistical Methods in Biomarker and Early Clinical Development
96% match

Statistical Methods in Biomarker and Early Clinical Development

Springer

£105.00 09 Mar 2026
Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)
96% match

Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£45.07 07 Mar 2026
Multiple Testing Problems in Pharmaceutical Statistics: 33 (Chapman & Hall/CRC Biostatistics Series)
96% match

Multiple Testing Problems in Pharmaceutical Statistics: 33 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£92.00 25 Jan 2026
Medical Product Safety Evaluation: Biological Models and Statistical Methods (Chapman & Hall/CRC Biostatistics Series)
96% match

Medical Product Safety Evaluation: Biological Models and Statistical Methods (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£62.35 02 Mar 2026
Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)
96% match

Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£42.31 28 Feb 2026
Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)
96% match

Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£110.95 25 Feb 2026
Statistical Thinking for Non-Statisticians in Drug Regulation
96% match

Statistical Thinking for Non-Statisticians in Drug Regulation

Wiley-Blackwell

£60.99 25 Jan 2026
New Drug Development: An Introduction to Clinical Trials: Second Edition
96% match

New Drug Development: An Introduction to Clinical Trials: Second Edition

Springer

£212.21 25 Jan 2026
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)
96% match

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£75.00 27 Feb 2026
Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)
96% match

Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Springer

£49.90 18 Feb 2026
Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)
96% match

Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Springer

£43.87 15 Feb 2026